Online citations, reference lists, and bibliographies.
← Back to Search

Investigation Of 3-D Ordered Materials With A High Adsorption Capacity For BSA And Their Potential Application As An Oral Vaccine Adjuvant.

Q. Zhang, Q. Zhao, Y. Zhang, N. Han, L. Hu, C. Zhang, T. Jiang, S. Wang
Published 2014 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
3-D ordered macroporous (3DOM) materials were customized for BSA adsorption and further oral immunization. These carriers have a high adsorption capacity and our customized carrier showed a distinctive double-plateau adsorption behavior. Different BSA release rates (between the two plateaus) could be obtained by adjusting the ratio of the protein adsorbed on the internal surface and the external surface. This suggests that the release pattern was determined by the adsorption state. One benefit is that the same carrier could have different release profiles making it possible to study the relationship between the release behavior and adjuvant effects without any distractions. Compared with free BSA alone, a significantly higher level of serum IgG, IgA induced by BSA/3DOM was observed and the release profile had an effect on the immunity. The IgG1 and IgG2a titers suggesting that both the Th1 and Th2 mediated immune response were induced. Therefore, this research could help in the development of a novel inorganic oral adjuvant and provide a new avenue for the administration of oral vaccine.
This paper references
10.1126/SCIENCE.281.5376.538
Synthesis of macroporous minerals with highly ordered three-dimensional arrays of spheroidal voids
Holland (1998)
10.1016/j.ijpharm.2009.11.012
Release profile of insulin entrapped on mesoporous materials by freeze-thaw method.
Y. Tozuka (2010)
10.1016/j.addr.2008.03.012
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
I. Slowing (2008)
10.1016/S0169-409X(02)00073-X
Immunological aspects of controlled antigen delivery.
S. Lofthouse (2002)
10.1016/S0168-3659(03)00093-2
Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity.
Seiichiro Minato (2003)
10.1006/SMIM.2000.0253
Localization dose and time of antigens determine immune reactivity.
R. Zinkernagel (2000)
10.1016/j.carbpol.2012.07.045
Chitosan matrix with three dimensionally ordered macroporous structure for nimodipine release.
Yuling Xie (2012)
10.1021/CM103704S
Hierarchically Ordered Macro-/Mesoporous Silica Monolith: Tuning Macropore Entrance Size for Size-Selective Adsorption of Proteins
Z. Sun (2011)
10.1039/B401890G
Structural and electrochemical properties of three-dimensionally ordered macroporous tin(IV) oxide films
Justin C. Lytle (2004)
10.1021/MA00214A013
Dispersion polymerization of styrene in polar solvents. 7. A simple mechanistic model to predict particle size
A. J. Paine (1990)
10.1016/J.AJPS.2013.11.001
Dissolution improvement of fenofibrate by melting inclusion in mesoporous silica
Fumiaki Uejo (2013)
10.1021/BM034497R
Novel thymine-functionalized polystyrenes for applications in biotechnology. 2. Adsorption of model proteins.
J. Puskas (2004)
10.1016/j.ijpharm.2012.06.028
Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.
T. Wang (2012)
10.1016/j.vaccine.2010.09.087
Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15.
Luciana V. Carvalho (2010)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1016/J.APCATB.2009.05.001
Creation of three-dimensionally ordered macroporous Au/CeO2 catalysts with controlled pore sizes and their enhanced catalytic performance for formaldehyde oxidation
J. Zhang (2009)
10.1021/JA056278E
Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry.
P. Roach (2006)
10.1016/J.JCONREL.2006.08.013
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
10.1016/J.POWTEC.2008.09.001
Controllable release of ibuprofen from size-adjustable and surface hydrophobic mesoporous silica spheres
Wujun Xu (2009)
10.1016/j.ejps.2011.10.012
Synthesis of a novel kind of carbon nanoparticle with large mesopores and macropores and its application as an oral vaccine adjuvant.
T. Wang (2011)
10.1016/j.jconrel.2005.02.027
Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles
Y. J. Kwon (2005)
10.1021/LA050588T
Probing BSA binding to citrate-coated gold nanoparticles and surfaces.
S. Brewer (2005)
10.1002/SMLL.200500274
Ordered mesoporous silica SBA-15: a new effective adjuvant to induce antibody response.
L. P. Mercuri (2006)
10.3109/08830180903349644
Perforin: More than Just a Pore-Forming Protein
F. Zhou (2010)
10.1016/j.ejpb.2011.07.001
Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy.
Y. Hu (2011)
10.1016/j.ijpharm.2009.12.013
PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B.
A. K. Jain (2010)
Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes.
Y. Sanchez (1980)
10.1016/J.MICROMESO.2009.10.008
Magnetic 3-D ordered macroporous silica templated from binary colloidal crystals and its application for effective removal of microcystin
J. Liu (2010)
10.1021/la202907f
General description of the adsorption of proteins at their iso-electric point in nanoporous materials.
Lung-Ching Sang (2011)
10.1016/j.ijpharm.2013.11.050
Poly dimethyl diallyl ammonium coated CMK-5 for sustained oral drug release.
C. Zhang (2014)



This paper is referenced by
10.1007/s10854-018-9299-2
Controlling the size of connecting windows in three-dimensionally ordered macroporous TiO2 for enhanced photocatalytic activity
Man Zhou (2018)
10.1016/j.vaccine.2019.09.005
Antigenic and physicochemical characterization of Hepatitis B surface protein under extreme temperature and pH conditions.
J. Lopes (2019)
10.1080/10837450.2019.1689402
An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery
Faten Madani (2019)
10.1134/S2075113319020102
Effects of Synthesis Method and Stabilizing Agent Trehalose on Functional Properties of Protein Composites with Colloidal Silica
E. S. Dolinina (2019)
10.1021/acsami.6b10470
Chemical Synthesis, Versatile Structures and Functions of Tailorable Adjuvants for Optimizing Oral Vaccination.
L. Zhang (2016)
10.1039/C8QM00467F
Anchoring nickel nanoparticles on three-dimensionally macro-/mesoporous titanium dioxide with a carbon layer from polydopamine using polymethylmethacrylate microspheres as sacrificial templates
J. Zheng (2019)
10.2147/IJN.S154743
Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination
L. Zhang (2018)
10.1016/j.addr.2017.04.008
Current state and challenges in developing oral vaccines.
Julia E. Vela Ramirez (2017)
10.1016/j.ijpharm.2015.04.045
Investigation of 3D ordered macroporous carbon with different polymer coatings and their application as an oral vaccine carrier.
Q. Zhao (2015)
10.1016/j.jcis.2014.12.033
Probing the anticancer-drug-binding-induced microenvironment alterations in subdomain IIA of human serum albumin.
X. Xu (2015)
Semantic Scholar Logo Some data provided by SemanticScholar